The WHO Pandemic Agreement, adopted on May 20 at the World Health Assembly, is designed to tackle the shortcomings revealed during the COVID-19 pandemic. One significant finding was that existing intellectual property rules failed to ensure timely and equitable access to health products. The limitations of patent permissions highlighted the necessity of addressing manufacturing capacity deficits to facilitate broader access to critical health resources during health emergencies.
The WHO Pandemic Agreement aims to address the inadequacies exposed by the COVID-19 pandemic, focusing on ensuring timely and equitable access to health products.
Existing intellectual property rules were found inadequate during the COVID-19 crisis, as patent permissions did not resolve manufacturing capacity challenges.
Collection
[
|
...
]